Amy Elazzouzi Biography and Net Worth

SVP of Aura Biosciences

Amy Elazzouzi is the SVP of Aura Biosciences. They are 52 years old.

What is Amy Elazzouzi's net worth?: The estimated net worth of Amy Elazzouzi is at least $470.85 thousand as of January 20th, 2026. Elazzouzi owns 84,081 shares of Aura Biosciences stock worth more than $470,854 as of February 6th. This net worth approximation does not reflect any other investments that Elazzouzi may own. Learn More about Amy Elazzouzi's net worth.
How do I contact Amy Elazzouzi?: The corporate mailing address for Elazzouzi and other Aura Biosciences executives is , , . Aura Biosciences can also be reached via phone at 617-500-8864 and via email at [email protected]. Learn More on Amy Elazzouzi's contact information.
Has Amy Elazzouzi been buying or selling shares of Aura Biosciences?: Within the last three months, Amy Elazzouzi has sold $7,683.66 in Aura Biosciences stock. Most recently, Amy Elazzouzi sold 1,581 shares of the business's stock in a transaction on Tuesday, January 20th. The shares were sold at an average price of $4.86, for a transaction totalling $7,683.66. Following the completion of the sale, the senior vice president now directly owns 84,081 shares of the company's stock, valued at $408,633.66. Learn More on Amy Elazzouzi's trading history.
Who are Aura Biosciences' active insiders?: Aura Biosciences' insider roster includes Elisabet de los Pinos (Insider), Amy Elazzouzi (SVP), Anthony Gibney (Insider), Janet Hopkins (Chief Medical Officer and President of Research & Development), David Johnson (Director), Conor Kilroy (Insider), and Mark Plavsic (CTO). Learn More on Aura Biosciences' active insiders.
Are insiders buying or selling shares of Aura Biosciences?: In the last twelve months, Aura Biosciences insiders bought shares 2 times. They purchased a total of 70,000 shares worth more than $343,000.00. In the last twelve months, insiders at the sold shares 13 times. They sold a total of 81,121 shares worth more than $474,102.33. The most recent insider tranaction occured on January, 20th when SVP Amy Elazzouzi sold 1,581 shares worth more than $7,683.66. Insiders at Aura Biosciences own 6.3% of the company. Learn More about insider trades at Aura Biosciences.
Information on this page was last updated on 1/20/2026.

Amy Elazzouzi Insider Trading History at Aura Biosciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/20/2026	Sell	1,581	$4.86	$7,683.66	84,081
10/29/2025	Sell	896	$6.35	$5,689.60	85,662
8/18/2025	Sell	7,722	$6.70	$51,737.40	86,558
4/16/2025	Sell	897	$5.49	$4,924.53	81,381
2/18/2025	Sell	1,404	$7.75	$10,881.00	82,278
1/21/2025	Sell	1,001	$7.67	$7,677.67	38,442
10/29/2024	Sell	553	$10.74	$5,939.22	39,443

Amy Elazzouzi Buying and Selling Activity at Aura Biosciences

Aura Biosciences Company Overview

Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer as an alternative to bacillus calmetteguérin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $5.60

$5.33

$5.63

50 Day Range

MA: $5.70

$4.97

$6.54

2 Week Range

Now: $5.60

$4.34

$8.16

Volume

221,524 shs

Average Volume

174,083 shs

Market Capitalization

$355.60 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.46